Onset Of Hfsr In Patients Within The First Cycle Of Regorafenib
Onset of HFSR in patients within the first cycle of regorafenib ...
Onset of HFSR in patients within the first cycle of regorafenib ...
Onset of HFSR in patients within the first cycle of regorafenib ...
Onset of HFSR in patients within the first cycle of regorafenib ...
Time to first onset of HFSR/HFS by the Kaplan-Meier method during the ...
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients ...
Efficacy and safety of regorafenib in patients with advanced pretreated ...
Dose modification/delay of regorafenib in patients with handfoot skin ...
Efficacy and safety of regorafenib in patients with advanced pretreated ...
Dose modification/delay of regorafenib in patients with handfoot skin ...
Advertisement Space (300x250)
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients ...
Kaplan-Meier curves of OS from the first regorafenib administration ...
A phase Ib study of the combination regorafenib with PF-03446962 in ...
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients ...
Safety and efficacy of regorafenib in patients with treatment ...
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients ...
Safety and efficacy of regorafenib in patients with treatment ...
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese ...
Cumulative occurrence of HFSR by cycle indicated as proportion of all ...
Effect of second-line regorafenib after first-line T+A progression in ...
Advertisement Space (336x280)
Recommendations for the Prophylaxis and Management of HFSR Timing ...
Cumulative occurrence of HFSR by cycle indicated as proportion of all ...
Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder ...
Elevated levels of sunitinib and FasL in the plasma and blister fluids ...
Evolution of regorafenib from bench to bedside in colorectal cancer: I ...
Algorithm for the management of TKI-related HFSR (recommendations from ...
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic ...
| The model of AI-HFSR in liver cancer. By impeding the reparation of ...
In vitro antiproliferation activity of regorafenib against vascular and ...
An open-label single-arm phase II study of regorafenib for the ...
Advertisement Space (336x280)
(PDF) Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ...
Regorafenib Mechanism Of Action
A phase II trial of the effect of perindopril on hand–foot skin ...
Regorafenib and glioblastoma: a literature review of preclinical ...
A phase II trial of the effect of perindopril on hand–foot skin ...
Regorafenib Mechanism Of Action